01 16NEUROCRINE
01 410905690
02 411311544
03 411730739
04 412128033
01 4Y
02 12Blank
01 16Blank
01 122035-01-21
02 42041-06-09
Patent Expiration Date : 2041-06-09
US Patent Number : 12128033
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-06-09
Patent Expiration Date : 2041-06-09
US Patent Number : 12128033
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-06-09
Patent Expiration Date : 2041-06-09
US Patent Number : 12128033
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-06-09
Patent Expiration Date : 2035-01-21
US Patent Number : 10905690
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 10905690
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 10905690
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11311544
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11311544
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11311544
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
Patent Expiration Date : 2035-01-21
US Patent Number : 11730739
Drug Substance Claim :
Drug Product Claim :
Application Number : 218808
Patent Use Code : U-4049
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-01-21
